Albers Jeffrey W.'s Form 4 filing
Blueprint Medicines Corp (BPMC) · filed Dec 20, 2024
- Accession no.
- 0001415889-24-029971
- Filed
- Dec 20, 2024
- Trade date
- Dec 19, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.35M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Albers Jeffrey W.CIK 0001638474 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $36.05 | +$540,750 | 172,557 | Direct | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −3,920 | $88.28 | −$346,057.6 | 168,637 | Direct | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −5,180 | $89.01 | −$461,071.8 | 163,457 | Direct | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −3,800 | $91.15 | −$346,370 | 159,657 | Direct | |
| Dec 19, 2024 | Common Stock | SSaleDisposed | −2,100 | $91.96 | −$193,116 | 157,557 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 19, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $36.05 | −$540,750 | 120,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.